Clinical Trial Update: A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety of PEG-Hirudin (SPP200) versus heparin in patients on haemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Vascular Graft Occlusion

Drugs mentioned

• Heparin (unfractionated heparin)
• PEG-Hirudin (SPP200) (pegylated hirudin)

Snippet

Sponsor: Speedel Pharma Ltd. | Conditions: Chronic Kidney Failure, Vascular Graft Occlusion | Phase 2 | Status: COMPLETED